The Basics
What is Iomeprol?
Helps optimize images obtained with sophisticated multidetector computed tomography (MDCT) technology, especially for neurological, brain, liver, cardiac and vascular scanning.
Brand names for Iomeprol
N/A
How Iomeprol is classified
Contrast Media, Diagnostic Agents
Iomeprol During Pregnancy
Iomeprol pregnancy category
Category N/ANote that the FDA has deprecated the use of pregnancy categories, so for some medications, this information isn’t available. We still think it’s useful to list historical info, however, given what a common proxy this has been in the past.
What we know about taking Iomeprol while pregnant
N/A
Taking Iomeprol While Breastfeeding
What are recommendations for lactation if you're taking Iomeprol?
Iomeprol is not approved for marketing in the United States by the U.S. Food and Drug Administration, but is available in other countries. Labeling for the drug in the United Kingdom and guidelines developed by several professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a iodine-containing contrast medium such as iomeprol.[1][2][3][4][5]
Maternal / infant drug levels
Iomeprol is not approved for marketing in the United States by the U.S. Food and Drug Administration, but is available in other countries. Labeling for the drug in the United Kingdom and guidelines developed by several professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a iodine-containing contrast medium such as iomeprol.[1][2][3][4][5]
Possible effects of Iomeprol on milk supply
Relevant published information was not found as of the revision date.
Possible alternatives to Iomeprol
Diatrizoate.
List of References
Lactation sources: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/1. Iomeron 400. Summary of product characteristics. February 28, 2018. www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1521177307697.pdf
2. American College of Radiology Committee on Drugs and Contrast Media. Administration of contrast media to breast-feeding mothers. In, ACR manual on contrast media. 2017;Version 10.3:102-3. https://www.acr.org/~/media/37D84428BF1D4E1B9A3A2918DA9E27A3.pdf
3. Webb JA, Thomsen HS, Morcos SK et al. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15:1234-40. PMID: 15609057
4. Chen MM, Coakley FV, Kaimal A, Laros RK Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 2008;112:333-40. PMID: 18669732
5. Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol. 2017;130:e210-e216. PMID: 28937575
6. Nielsen ST, Matheson I, Rasmussen JN et al. Excretion of iohexol and metrizoate in human breast milk. Acta Radiol. 1987;28:523-6. PMID: 2960342
Disclaimer: This material is provided for educational purposes only and is not intended for medical advice, diagnosis, or treatment. Consult your healthcare provider with any questions.
